We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$16.4B
AUM Growth
+$2.8B
Cap. Flow
+$574M
Cap. Flow %
3.49%
Top 10 Hldgs %
21.48%
Holding
1,573
New
122
Increased
458
Reduced
207
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 16.65%
3 Consumer Discretionary 14.09%
4 Financials 11.64%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLIO icon
1426
Helios Technologies
HLIO
$2.7B
$286K ﹤0.01%
+5,358
New +$252K
KRG icon
1427
Kite Realty
KRG
$5.3B
$286K ﹤0.01%
19,125
RMBS icon
1428
Rambus
RMBS
$10.9B
$286K ﹤0.01%
16,397
CATM
1429
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$286K ﹤0.01%
+8,100
New +$202K
HTH icon
1430
Hilltop Holdings
HTH
$2.27B
$282K ﹤0.01%
10,246
SBH icon
1431
Sally Beauty Holdings
SBH
$1.54B
$282K ﹤0.01%
21,634
INOV
1432
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$281K ﹤0.01%
15,453
ADT icon
1433
ADT
ADT
$5.31B
$279K ﹤0.01%
35,600
+19,800
+125% +$156K
LNN icon
1434
Lindsay Corp
LNN
$1.16B
$279K ﹤0.01%
2,172
PRIM icon
1435
Primoris Services
PRIM
$4.32B
$279K ﹤0.01%
10,109
LGF.A
1436
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$278K ﹤0.01%
24,418
LTC
1437
LTC Properties
LTC
$2.12B
$277K ﹤0.01%
7,130
TEVA icon
1438
Teva Pharmaceuticals
TEVA
$43B
$277K ﹤0.01%
28,700
ROIC
1439
DELISTED
Retail Opportunity Investments Corp.
ROIC
$277K ﹤0.01%
20,697
CVA
1440
DELISTED
Covanta Holding Corporation
CVA
$277K ﹤0.01%
21,090
EIG icon
1441
Employers Holdings
EIG
$869M
$275K ﹤0.01%
8,537
HRTX icon
1442
Heron Therapeutics
HRTX
$63.6M
$275K ﹤0.01%
13,000
INGN icon
1443
Inogen
INGN
$154M
$275K ﹤0.01%
+6,165
New +$213K
MCY icon
1444
Mercury Insurance
MCY
$5.84B
$275K ﹤0.01%
5,258
SBSI icon
1445
Southside Bancshares
SBSI
$981M
$273K ﹤0.01%
8,809
SGMO
1446
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$272K ﹤0.01%
17,446
UHAL icon
1447
U-Haul Holding Co
UHAL
$14.5B
$272K ﹤0.01%
+6,000
New +$239K
CBPO
1448
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$272K ﹤0.01%
2,300
RUSHA icon
1449
Rush Enterprises Class A
RUSHA
$9.52B
$270K ﹤0.01%
9,789
-1
-0% -$26
VRM icon
1450
Vroom Inc
VRM
$52.3M
$270K ﹤0.01%
+83
New +$274K

Similar funds

Handelsbanken Fonder's Q4 2020 Portfolio in Review

As of Q4 2020, Handelsbanken Fonder held 1,573 positions worth $16.4B, up 21% from $13.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Handelsbanken Fonder deployed $574M of net new capital in Q4 2020, opening 122 new positions and adding to 458 existing holdings. Its largest new stake was Hyliion Holdings: 2,076,551 shares worth $34.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Daqo New Energy, an estimated $49.1M trimmed.

  • Handelsbanken Fonder's largest Q4 2020 buy was Hyliion Holdings: 2,076,551 shares worth $34.2M.
  • Handelsbanken Fonder added most to Sunrun in Q4 2020, an estimated $59.8M increase.
  • Handelsbanken Fonder's biggest Q4 2020 reduction was Daqo New Energy, cutting an estimated $49.1M.
  • Handelsbanken Fonder fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $14M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $16.4B portfolio in Q4 2020.
  • Handelsbanken Fonder opened 122 new positions and closed 28 in Q4 2020.
  • Handelsbanken Fonder's portfolio value rose 21% quarter-over-quarter to $16.4B.

Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.